The Cigna Group
The Cigna Group (CI)
Overview
The Cigna Group is a multinational health services and insurance company that combines a traditional health insurance business with one of the country's largest pharmacy benefit management and specialty pharmacy operations. Headquartered in Bloomfield, Connecticut, and incorporated in Delaware, Cigna traces its roots to a 1982 merger of Connecticut General Life Insurance Company (founded 1865) and INA Corporation (founded 1792), and took its current holding-company name, "The Cigna Group," after its 2018 acquisition of pharmacy benefit manager Express Scripts. Cigna is a member of the S&P 500 and one of the largest companies in the U.S. by revenue — trailing-twelve-month revenue is roughly $280 billion, market capitalization is in the range of $75 billion, and the company employs on the order of 67,000–70,000 people, reflecting the low-margin, high-revenue-volume nature of health insurance and pharmacy claims processing.
What They Do & How They Make Money
Cigna makes money in two related but distinct ways. First, as a health insurer, it collects premiums from employers, unions, government programs, and individuals in exchange for managing and paying medical, dental, behavioral health, disability, and accident claims for the people it covers; profitability depends on accurately pricing risk, negotiating favorable rates with hospitals and physicians, and managing medical costs (the "medical loss ratio," or the share of premium dollars paid out in claims, is a key profitability lever). Second, through its Evernorth Health Services division, Cigna operates a large-scale pharmacy benefit manager (PBM) that negotiates drug prices and rebates with pharmaceutical manufacturers on behalf of health plans and employers, processes prescription drug claims, and runs specialty pharmacy and care management services for complex, high-cost conditions; this business earns money on a mix of administrative fees, spread pricing, and rebate retention. Increasingly, Cigna's strategy has been to sell Evernorth's PBM, specialty pharmacy, and care services not just to its own insurance customers but to competing health plans and employers as an independent, standalone business line — meaning a growing share of Evernorth's revenue actually comes from outside the traditional Cigna Healthcare insurance business.
Business Segments
Cigna reports its results across two primary segments:
- Evernorth Health Services — the larger segment by revenue, encompassing pharmacy benefit management, drug claim adjudication, specialty pharmacy distribution, and clinical/care management programs. Built around the 2018 Express Scripts acquisition, Evernorth serves both Cigna's own insurance members and a large base of external health plan and employer clients, and has become the primary growth engine of the company.
- Cigna Healthcare — the traditional health insurance business, offering employer-sponsored medical plans (self-funded administrative services and fully insured), individual and family plans, Medicare Advantage and supplemental products, behavioral health coverage, dental, stop-loss insurance for self-insured employers, and Cigna Global Health Benefits for expatriates and multinational employers.
Evernorth generates substantially more total revenue than Cigna Healthcare because pharmacy claims pass-through dollar volumes are very large relative to margin, while Cigna Healthcare, though smaller in reported revenue, has historically contributed a meaningful share of overall segment earnings given its differentiated insurance underwriting margins.
Competitors
Cigna competes across several distinct but overlapping markets:
- Health insurance: UnitedHealth Group (also a PBM/Optum competitor), Elevance Health (formerly Anthem), Humana, Aetna (part of CVS Health), Centene, and Molina Healthcare, among others.
- Pharmacy benefit management (Evernorth vs. rivals): CVS Health's Caremark, UnitedHealth Group's OptumRx, and to a lesser extent smaller independent PBMs.
- Specialty pharmacy and care services: CVS Health/Caremark Specialty, Optum Specialty Pharmacy, and various independent specialty pharmacy providers.
Competitive Position
Cigna's core competitive advantage is the same integrated "payer plus PBM" model that its two largest rivals, UnitedHealth Group and CVS Health, also pursue: by owning both the insurance/benefits side and the pharmacy claims/specialty pharmacy side of healthcare spending, Cigna can capture margin at multiple points in the healthcare value chain, cross-sell services, and use Evernorth's scale in drug purchasing to negotiate better rebates than a standalone insurer could achieve alone. Evernorth's scale — one of the top handful of PBMs in the country — gives it significant negotiating leverage with drug manufacturers and makes it attractive to external health plans and employers who want PBM services without building their own. Cigna has also deliberately positioned itself less as a direct-to-consumer individual/Medicare insurer (a category where UnitedHealth and Humana are dominant) and more toward large national and multinational employer accounts and specialty/complex pharmacy services, a differentiated niche within the broader managed care industry. Key risks include intense regulatory and political scrutiny of PBM pricing practices, drug rebate structures, and prior-authorization/claims-denial practices (an area of heightened public and legislative attention in the U.S. health insurance industry); rising medical cost trends that can outpace premium pricing; concentration risk from large employer and health plan clients; and the ever-present threat of further consolidation among competitors (e.g., insurer-PBM combinations at UnitedHealth/Optum and CVS/Aetna/Caremark) that intensifies competitive pressure on pricing and service differentiation.